Marker Therapeutics News - MRKR

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Marker Therapeutics Inc MRKR NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.09 -1.48% 5.98 6.10 5.93 6.08 6.07 12:18:20
more quote information »

Recent News

Date Time Source Heading
8/19/201917:09EDGARStatement of Changes in Beneficial Ownership (4)
8/19/201917:08EDGARInitial Statement of Beneficial Ownership (3)
8/15/201916:34EDGARStatement of Changes in Beneficial Ownership (4)
8/15/201916:18EDGARCurrent Report Filing (8-k)
8/15/201916:01PRNUSMarker Therapeutics Appoints Nadia Agopyan, Ph.D., RAC as..
8/09/201908:32EDGARQuarterly Report (10-q)
8/09/201906:11EDGARCurrent Report Filing (8-k)
8/06/201916:50EDGARCurrent Report Filing (8-k)
8/06/201916:05PRNUSMarker Therapeutics Appoints Steve Elms to its Board of..
7/22/201908:36EDGARCurrent Report Filing (8-k)
7/20/201911:00PRNUSMarker Therapeutics Reports Interim Results of its MultiTAA..
7/19/201909:14EDGARCurrent Report Filing (8-k)
7/17/201907:00PRNUSMarker Therapeutics to Host Conference Call and Webcast to..
6/26/201906:02EDGARNotice of Effectiveness (effect)
6/20/201907:06EDGARCurrent Report Filing (8-k)
6/20/201907:00PRNUSMarker Therapeutics to Report Updated Results from Phase 1/2..
6/14/201916:07EDGARSecurities Registration Statement (simplified Form) (s-3)
5/21/201907:00PRNUSMarker Therapeutics to Present at Two Upcoming Investor..
5/15/201916:12EDGARInitial Statement of Beneficial Ownership (3)
5/13/201916:03EDGARStatement of Changes in Beneficial Ownership (4)
5/13/201916:03EDGARStatement of Changes in Beneficial Ownership (4)
5/13/201916:03EDGARStatement of Changes in Beneficial Ownership (4)
5/13/201916:02EDGARStatement of Changes in Beneficial Ownership (4)
5/10/201917:07EDGARCurrent Report Filing (8-k)
5/10/201917:05EDGARQuarterly Report (10-q)
5/09/201917:11EDGARCurrent Report Filing (8-k)
5/09/201916:01PRNUSMarker Therapeutics Reports First Quarter 2019 Operating and..
5/07/201916:10PRNUSMarker Therapeutics to Present at the Bank of America..
4/17/201907:01EDGARCurrent Report Filing (8-k)
4/01/201913:58EDGARConfidential Treatment Order (ct Order)
3/28/201917:20EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
3/28/201917:16EDGARProxy Statement (definitive) (def 14a)
3/28/201917:12EDGARCurrent Report Filing (8-k)
3/28/201916:05PRNUSMarker Therapeutics Provides Business and Clinical Update
3/18/201907:00PRNUSMarker Therapeutics to Host Business Update Conference Call..
3/15/201917:05EDGARAnnual Report (10-k)
2/25/201908:53EDGARCurrent Report Filing (8-k)
2/25/201907:00PRNUSMarker Therapeutics Announces Clinical Update at the..
2/21/201918:00PRNUSMarker Therapeutics Congratulates Helen E. Heslop, MD, DSc..
2/20/201907:00PRNUSMarker Therapeutics to Present at the CAR-TCR Summit Europe
2/15/201916:56EDGARCurrent Report Filing (8-k)
2/15/201916:30PRNUSMarker Therapeutics Announces Change in Corporate..
2/14/201917:20EDGARStatement of Ownership (sc 13g)
2/14/201911:23EDGARStatement of Beneficial Ownership (sc 13d)
2/14/201911:20EDGARStatement of Beneficial Ownership (sc 13d)
2/14/201911:17EDGARStatement of Beneficial Ownership (sc 13d)
2/07/201907:00PRNUSMarker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as..
2/06/201907:00PRNUSMarker Therapeutics to Present at the 2019 BIO CEO &..
2/04/201909:30EDGARAmended Statement of Ownership (sc 13g/a)
1/29/201906:07EDGARProspectus Filed Pursuant to Rule 424(b)(7) (424b7)
See more news about this stock »


Your Recent History
NASDAQ
MRKR
Marker The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.